Literature DB >> 19127667

Awareness of health personnel about lymphatic filariasis and mass drug administration in Kerala State.

Ali M K Showkath1, K Regu, R Rajendran, M K Mohanan, B Ganesh.   

Abstract

The mass drug administration programme to eliminate lymphatic filariasis with DEC in Kerala was started in 1997, extended to all the 11 endemic districts by 2005. Since the beginning of Mass drug Administration, the drug consumption rate was found to be not satisfactory. The reasons for noncompliance indicated that the community is not fully convinced about the programme. The knowledge of the medical and para medical workers is certainly a factor in the success of implementation of the programme and is vital. To ascertain the knowledge, a study was undertaken and found not satisfactory. Hence intensive training on all aspects of lymphatic filariasis and the Mass drug Administration programme to achieve the requisite drug consumption rate to meet the goal is needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19127667

Source DB:  PubMed          Journal:  J Commun Dis        ISSN: 0019-5138


  4 in total

Review 1.  Community views on mass drug administration for filariasis: a qualitative evidence synthesis.

Authors:  Melissa Taylor; Rebecca Thomas; Sandy Oliver; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2022-02-17

2.  Awareness of health personnel about lymphatic filariasis and mass drug administration in Karnataka state of South India.

Authors:  N Joseph; Sh Subba; A Jain; B Unnikrishnan; K Nagaraj; Sm Kotian
Journal:  Australas Med J       Date:  2011-02-28

Review 3.  A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.

Authors:  Alison Krentel; Peter U Fischer; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21

4.  Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana.

Authors:  Alfred Kwesi Manyeh; Latifat Ibisomi; Rohit Ramaswamy; Frank Baiden; Tobias Chirwa
Journal:  PLoS Negl Trop Dis       Date:  2020-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.